Dimensional Fund Advisors’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.8M Buy
948,815
+32,476
+4% +$352K ﹤0.01% 2229
2025
Q4
$11.8M Sell
916,339
-239,327
-21% -$2.95M ﹤0.01% 2229
2025
Q3
$12.9M Sell
1,155,666
-16,916
-1% -$163K ﹤0.01% 2204
2025
Q2
$11.6M Buy
1,172,582
+7,013
+0.6% +$68.7K ﹤0.01% 2219
2025
Q1
$10.9M Sell
1,165,569
-323,098
-22% -$3.4M ﹤0.01% 2212
2024
Q4
$13.6M Buy
1,488,667
+135,007
+10% +$993K ﹤0.01% 2173
2024
Q3
$10.5M Buy
1,353,660
+240,750
+22% +$1.74M ﹤0.01% 2286
2024
Q2
$6.73M Sell
1,112,910
-242,478
-18% -$1.5M ﹤0.01% 2391
2024
Q1
$7.96M Sell
1,355,388
-133,720
-9% -$794K ﹤0.01% 2405
2023
Q4
$11.7M Sell
1,489,108
-181,635
-11% -$1.26M ﹤0.01% 2252
2023
Q3
$12.2M Sell
1,670,743
-452,427
-21% -$3.76M ﹤0.01% 2152
2023
Q2
$22.1M Sell
2,123,170
-360,576
-15% -$3.47M 0.01% 1883
2023
Q1
$25.7M Sell
2,483,746
-203,735
-8% -$2.61M 0.01% 1776
2022
Q4
$37K Buy
2,687,481
+18,369
+0.7% +$256K 0.01% 1510
2022
Q3
$54.6M Sell
2,669,112
-46,278
-2% -$1.02M 0.02% 1153
2022
Q2
$52.5M Sell
2,715,390
-35,482
-1% -$727K 0.02% 1253
2022
Q1
$59.3M Buy
2,750,872
+46,173
+2% +$1.05M 0.02% 1270
2021
Q4
$74.6M Sell
2,704,699
-84,920
-3% -$2.34M 0.02% 1110
2021
Q3
$72.4M Sell
2,789,619
-42,121
-1% -$1.13M 0.02% 1110
2021
Q2
$76.8M Sell
2,831,740
-21,664
-0.8% -$529K 0.02% 1074
2021
Q1
$66.9M Sell
2,853,404
-73,635
-3% -$1.49M 0.02% 1174
2020
Q4
$44.9M Sell
2,927,039
-101,283
-3% -$1.29M 0.02% 1457
2020
Q3
$36.5M Sell
3,028,322
-45,687
-1% -$434K 0.02% 1453
2020
Q2
$31.3M Sell
3,074,009
-55,652
-2% -$574K 0.01% 1575
2020
Q1
$32.6M Buy
3,129,661
+1,787
+0.1% +$22.4K 0.02% 1409
2019
Q4
$50.1M Sell
3,127,874
-7,382
-0.2% -$113K 0.02% 1431
2019
Q3
$57.8M Buy
3,135,256
+6,900
+0.2% +$135K 0.02% 1258
2019
Q2
$61.6M Buy
3,128,356
+11,776
+0.4% +$240K 0.02% 1196
2019
Q1
$71.2M Buy
3,116,580
+7,902
+0.3% +$172K 0.03% 993
2018
Q4
$62.6M Sell
3,108,678
-11,418
-0.4% -$236K 0.03% 989
2018
Q3
$67.8M Buy
3,120,096
+36,796
+1% +$817K 0.03% 1102
2018
Q2
$68.6M Sell
3,083,300
-7,455
-0.2% -$152K 0.03% 1050
2018
Q1
$53.3M Sell
3,090,755
-8,361
-0.3% -$139K 0.02% 1270
2017
Q4
$51.5M Buy
3,099,116
+13,311
+0.4% +$227K 0.02% 1327
2017
Q3
$52.7M Sell
3,085,805
-29,548
-0.9% -$496K 0.02% 1247
2017
Q2
$50.5M Sell
3,115,353
-13,424
-0.4% -$212K 0.02% 1228
2017
Q1
$54.3M Buy
3,128,777
+14,823
+0.5% +$248K 0.03% 1095
2016
Q4
$52.5M Buy
3,113,954
+18,450
+0.6% +$308K 0.03% 1063
2016
Q3
$54.3M Buy
3,095,504
+127,120
+4% +$2.06M 0.03% 944
2016
Q2
$42.7M Buy
2,968,384
+121,841
+4% +$1.52M 0.02% 1145
2016
Q1
$35M Buy
2,846,543
+44,658
+2% +$493K 0.02% 1315
2015
Q4
$34M Sell
2,801,885
-28,054
-1% -$345K 0.02% 1265
2015
Q3
$37.3M Buy
2,829,939
+28,842
+1% +$435K 0.02% 1102
2015
Q2
$45.9M Buy
2,801,097
+105,014
+4% +$1.74M 0.03% 952
2015
Q1
$48M Buy
2,696,083
+144,630
+6% +$2.69M 0.03% 872
2014
Q4
$48.5M Buy
2,551,453
+141,498
+6% +$2.4M 0.03% 786
2014
Q3
$33.1M Buy
2,409,955
+8,707
+0.4% +$124K 0.02% 1061
2014
Q2
$39.2M Buy
2,401,248
+76,521
+3% +$1.11M 0.03% 940
2014
Q1
$36.6M Buy
2,324,727
+82,471
+4% +$1.34M 0.03% 922
2013
Q4
$38.5M Buy
2,242,256
+130,647
+6% +$2.01M 0.03% 831
2013
Q3
$27.9M Buy
2,111,609
+8,317
+0.4% +$98.1K 0.02% 1032
2013
Q2
$23.7M Buy
+2,103,292
New +$22.4M 0.02% 1081

Other funds holding ANGO

Dimensional Fund Advisors's ANGO Position: Q1 2026 in Review

Dimensional Fund Advisors increased its AngioDynamics (ANGO) stake by 3.5% in Q1 2026, buying an estimated $352K and bringing the position to 948,815 shares worth $10.8M. The position accounts for ﹤0.01% of the portfolio, ranked #2229.

Dimensional Fund Advisors first reported a position in ANGO in Q2 2013 and has held it in 52 quarters since. The position peaked at $76.8M in Q2 2021. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.

  • Dimensional Fund Advisors held 948,815 shares of AngioDynamics worth $10.8M as of Q1 2026.
  • Dimensional Fund Advisors bought 32,476 AngioDynamics shares in Q1 2026, an estimated $352K.
  • AngioDynamics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2229 holding.
  • Dimensional Fund Advisors first reported a position in AngioDynamics in Q2 2013 and has held it in 52 quarters since.
  • Dimensional Fund Advisors's AngioDynamics position peaked at $76.8M in Q2 2021.
  • 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.